CHU de Liege /ID# 276500

Liège 4000

1 studies enrolling now · 1 studies all time

What they study most

Ovarian Cancer

Studies at this site

• A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer — Recruiting now